US Drug Recall Register

FDA Drug Recalls

1,739 recalls · Class I, newest first

Class I · High risk Terminated

Prolotherapy with Phenol

Reason Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Hartley Medical Center Pharmacy, Incorporated D-1830-2015
Class I · High risk Terminated

Prolotherapy with Phenol

Reason Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Hartley Medical Center Pharmacy, Incorporated D-1829-2015
Class I · High risk Terminated

KABOOM action strips

Reason Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.

Blue Square Market, Inc. D-0297-2016
Class I · High risk Terminated

LiDa DAIDAIHUA

Reason Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.

Blue Square Market, Inc. D-0296-2016
Class I · High risk Terminated

Adrucil

Reason Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution

Teva Pharmaceuticals USA NDC 0703-3019-12 D-1351-2015
Class I · High risk Terminated

0.9% Sodium Chloride Injection USP

Reason Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.

Baxter Healthcare Corp. NDC 0338-0049-11 D-1336-2015
Class I · High risk Terminated

0.9% Sodium Chloride Injection USP MINI-BAG Plus Container

Reason Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.

Baxter Healthcare Corp. NDC 0338-0553-18 D-1335-2015
Class I · High risk Terminated

fentaNYL Citrate

Reason Subpotent Drug: confirmed subpotency in one lot of this product that was packaged and stored in syringes.

Pharmedium Services, LLC D-0093-2017
Class I · High risk Ongoing

Zero Xtreme High Performance Fat Burner capsules

Reason Marketed Without an Approved NDA/ANDA: FDA sampling and analysis confirmed the presence of sibutramine and desmethylsibutramine.

Xtreme Z Distributors INC D-1165-2016
Class I · High risk Terminated

PYROLA Advanced Joint Formula capsules

Reason Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared diclofenac, a prescription non-steroidal anti-inflammatory drug, and chlorpheniramine, an over-the-counter antihistimine, making this an unapproved drug.

GC Natural Nutrition, Inc. D-1330-2015
Class I · High risk Terminated

Smart Lipo Dietary Supplement capsules

Reason Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.

Centro Naturista D-0878-2016
Class I · High risk Terminated

Smart Lipo Dietary Supplement capsules

Reason Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.

Centro Naturista D-0877-2016
Class I · High risk Terminated

Morphine Sulfate

Reason Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.

Pharmedium Services, LLC NDC 61553-401-44 D-0658-2016
Class I · High risk Terminated

Adrucil

Reason Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.

Teva Pharmaceuticals USA NDC 0703-3019-11 D-1089-2015
Class I · High risk Terminated

Cytarabine Injection 100 mg/5 mL

Reason Presence of Particulate Matter

Mylan Institutional LLC NDC 0069-0152-01 D-1329-2015
Class I · High risk Terminated

Bupivacaine Hydrochloride Inj.

Reason Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.

Hospira Inc. D-1216-2015